Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBYN DAWN HARTVICKSON

Allopathic & Osteopathic Physicians Family Medicine

NPI
1679532659
CMS profile
303021
Location
NEWTON, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$1,012.70

73 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,012.70 73

By paying entity

PY2022 · entire year · sorted by reported total

Page 1 of 2; records 1–50 of 73 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROBYN DAWN HARTVICKSON

NPI 1679532659 · CMS profile ID 303021

Allopathic & Osteopathic Physicians / Family Medicine

NEWTON, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 2; records 1–50 of 73 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1679532659?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROBYN DAWN HARTVICKSON, NPI 1679532659, CMS profile ID 303021. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 73 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1679532659?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ROBYN DAWN HARTVICKSON, NPI 1679532659, CMS profile ID 303021. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 2; records 1–50 of 73 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1679532659?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ROBYN DAWN HARTVICKSON, NPI 1679532659, CMS profile ID 303021, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 2; records 1–50 of 73 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1679532659?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

73 matching records · $1,012.70 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 73 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 73.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Sunovion Pharmaceuticals Inc. $27.1812/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920946885 CMS
ABBVIE INC. $30.5712/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759361 CMS
PFIZER INC. $20.4311/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949475241 CMS
ABBVIE INC. $0.8011/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759357 CMS
Merck Sharp & Dohme LLC $19.8911/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944404807 CMS
Amgen Inc. $22.7511/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940059027 CMS
Daiichi Sankyo Inc. $12.5911/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930872093 CMS
Biohaven Pharmaceutical Holding Company Ltd. $19.0911/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923612207 CMS
PFIZER INC. $11.8410/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949397635 CMS
ABBVIE INC. $17.7810/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759353 CMS
Daiichi Sankyo Inc. $15.4510/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930870991 CMS
ABBVIE INC. $8.4110/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759347 CMS
ABBVIE INC. $0.8910/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759351 CMS
Bayer HealthCare Pharmaceuticals Inc. $12.5910/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929953773 CMS
Lilly USA, LLC $15.1410/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 918292843 CMS
Novo Nordisk Inc $12.9710/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899078859 CMS
Biohaven Pharmaceutical Holding Company Ltd. $15.5709/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923612205 CMS
ABBVIE INC. $6.0409/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759343 CMS
Amgen Inc. $16.5009/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939232037 CMS
ABBVIE INC. $8.7008/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759333 CMS
ABBVIE INC. $15.4608/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759337 CMS
ABBVIE INC. $1.2308/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759339 CMS
Bayer HealthCare Pharmaceuticals Inc. $12.2708/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930256521 CMS
ABBVIE INC. $2.8308/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759329 CMS
GlaxoSmithKline, LLC. $19.5208/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944572867 CMS
PFIZER INC. $24.0208/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949252613 CMS
ABBVIE INC. $1.6607/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759323 CMS
ABBVIE INC. $8.6607/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759325 CMS
Amgen Inc. $11.1207/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939232035 CMS
Biohaven Pharmaceutical Holding Company Ltd. $17.1407/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923612203 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.4507/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887332665 CMS
ABBVIE INC. $2.9907/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759319 CMS
Novo Nordisk Inc $12.0007/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899078851 CMS
AstraZeneca Pharmaceuticals LP $12.7807/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915807677 CMS
ABBVIE INC. $25.4807/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759315 CMS
Sunovion Pharmaceuticals Inc. $19.5707/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920991003 CMS
Amgen Inc. $21.2006/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939232033 CMS
Biohaven Pharmaceutical Holding Company Ltd. $19.5206/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923612201 CMS
PFIZER INC. $20.2206/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949228273 CMS
Biohaven Pharmaceutical Holding Company Ltd. $12.3606/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923612199 CMS
ABBVIE INC. $16.9005/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759313 CMS
Amgen Inc. $16.4205/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939232027 CMS
ABBVIE INC. $2.4405/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759309 CMS
Sunovion Pharmaceuticals Inc. $10.7205/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921104665 CMS
ABBVIE INC. $7.2805/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759305 CMS
Biohaven Pharmaceutical Holding Company Ltd. $13.5305/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 923612197 CMS
ABBVIE INC. $4.9704/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759301 CMS
Bayer HealthCare Pharmaceuticals Inc. $12.0404/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929985235 CMS
ABBVIE INC. $19.7404/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 892759299 CMS
Novo Nordisk Inc $15.5704/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 899173535 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $349.87 24
PY2020 $259.38 18
PY2021 $867.92 59
PY2022 $1,012.70 73
PY2023 $2,574.33 71
PY2024 $862.16 54
PY2025 $813.93 47

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $136,207.90 39
PY2024 Principal investigator $344,898.92 54
PY2023 Principal investigator $702,129.77 95
PY2022 Principal investigator $153,146.27 62
PY2021 Principal investigator $143,310.07 45
PY2020 Principal investigator $223,270.91 168
PY2019 Principal investigator $302,825.41 141

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

39 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ModernaTX, Inc. $2,825.55 11/21/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979152
Principal investigator 1 ModernaTX, Inc. $810.00 11/21/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979178
Principal investigator 1 ModernaTX, Inc. $320.00 11/21/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979220
Principal investigator 1 ModernaTX, Inc. $3,624.75 10/22/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979210
Principal investigator 1 ModernaTX, Inc. $560.00 10/03/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979160
Principal investigator 1 ModernaTX, Inc. $6,885.00 10/03/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979222
Principal investigator 1 ModernaTX, Inc. $1,500.00 09/25/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979170
Principal investigator 1 ModernaTX, Inc. $1,200.00 09/25/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979174
Principal investigator 1 ModernaTX, Inc. $900.00 09/25/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979176
Principal investigator 1 ModernaTX, Inc. $8,336.25 09/19/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979212
Principal investigator 1 ModernaTX, Inc. $10,500.30 08/20/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979190
Principal investigator 1 ModernaTX, Inc. $500.00 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979148
Principal investigator 1 ModernaTX, Inc. $880.00 08/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979162
Principal investigator 1 ModernaTX, Inc. $17,536.50 07/18/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979184
Principal investigator 1 ModernaTX, Inc. $13,344.75 06/18/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979182
Principal investigator 1 ModernaTX, Inc. $81.00 06/05/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979146
Principal investigator 1 ModernaTX, Inc. $6,270.75 05/21/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979208
Principal investigator 1 ModernaTX, Inc. $120.00 05/02/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979168
Principal investigator 1 ModernaTX, Inc. $175.50 05/02/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979172
Principal investigator 1 ModernaTX, Inc. $500.00 05/02/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979206
Principal investigator 1 ModernaTX, Inc. $567.00 04/28/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979154
Principal investigator 1 ModernaTX, Inc. $303.75 04/28/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979166
Principal investigator 1 ModernaTX, Inc. $94.50 04/28/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979200
Principal investigator 1 ModernaTX, Inc. $243.00 04/28/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979204
Principal investigator 1 ModernaTX, Inc. $9,402.75 04/18/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979218
Principal investigator 1 ModernaTX, Inc. $1,500.00 04/02/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979188
Principal investigator 1 ModernaTX, Inc. $1,433.70 03/24/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979156
Principal investigator 1 ModernaTX, Inc. $1,285.20 03/24/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979158
Principal investigator 1 ModernaTX, Inc. $11,934.00 03/19/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979164
Principal investigator 1 ModernaTX, Inc. $27.00 03/05/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979192
Principal investigator 1 ModernaTX, Inc. $283.50 03/05/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979194
Principal investigator 1 ModernaTX, Inc. $33.75 03/05/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979196
Principal investigator 1 ModernaTX, Inc. $240.00 03/05/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979198
Principal investigator 1 ModernaTX, Inc. $94.50 03/05/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes No dispute reported 06/30/2026 1252979202
Principal investigator 1 ModernaTX, Inc. $910.00 03/03/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979150
Principal investigator 1 ModernaTX, Inc. $6,264.00 02/21/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979214
Principal investigator 1 ModernaTX, Inc. $1,440.00 02/03/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979216
Principal investigator 1 ModernaTX, Inc. $22,320.90 01/24/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979186
Principal investigator 1 ModernaTX, Inc. $960.00 01/03/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age No dispute reported 06/30/2026 1252979180